N-acetyl cysteine for the treatment of alcohol use disorder: study protocol for a multi-site, double-blind randomised controlled trial (NAC-AUD study)

Authors

Kirsten C. Morley (ORCID: https://orcid.org/0000-0002-0868-9928)
Jason P. Connor (ORCID: https://orcid.org/0000-0002-7020-1196)
Shalini Arunogiri (ORCID: https://orcid.org/0000-0002-7667-8868)
Paul J. Clark (ORCID: https://orcid.org/0000-0002-1821-4969)
Mary Lou Chatterton (ORCID: https://orcid.org/0000-0003-4902-9448)
Tim N Slade (ORCID: https://orcid.org/0000-0002-1725-9188)
Dan I. Lubman (ORCID: https://orcid.org/0000-0002-6747-1937)
Andrew Baillie (ORCID: https://orcid.org/0000-0003-3424-5703)
Paul Haber (ORCID: https://orcid.org/0000-0001-8915-8872)
Michael Berk (ORCID: https://orcid.org/0000-0003-2520-9903)

Institutions

The University of Sydney (AU)
Deakin University (AU)
The University of Queensland (AU)
Princess Alexandra Hospital (AU)
Cooperative Trials Group for Neuro-Oncology (AU)
Eastern Health (AU)
Sydney Local Health District (AU)
Monash University (AU)

Publication Details

Journal: BMJ Open
Published: 2025-09-01
DOI: https://doi.org/10.1136/bmjopen-2024-091631
Primary Topic: Substance Abuse Treatment and Outcomes
Type: article
Field-Weighted Citation Impact: 0.00

Funders

Medical Research Council
National Health and Medical Research Council

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

N-acetyl cysteine for the treatment of alcohol use disorder: study protocol for a multi-site, double-blind randomised controlled trial (NAC-AUD study)

Kirsten C. Morley, Jason P. Connor, Shalini Arunogiri, Paul J. Clark et al.

Sep 1, 2025

BMJ Open

Substance Abuse Treatment and Outcomes

article

N-acetyl cysteine for the treatment of alcohol use disorder: study protocol for a multi-site, double-blind randomised controlled trial (NAC-AUD study)

Kirsten C. Morley, Jason P. Connor, Shalini Arunogiri, Paul J. Clark, Mary Lou Chatterton, Tim N Slade, Dan I. Lubman, Andrew Baillie, Paul Haber, Michael Berk

September 1, 2025article en

Abstract

No abstract available for this paper.

BMJ OpenVol. 15(9)

The University of Sydney (AU), Deakin University (AU), The University of Queensland (AU), Princess Alexandra Hospital (AU), Cooperative Trials Group for Neuro-Oncology (AU), Eastern Health (AU), Sydney Local Health District (AU), Monash University (AU)

Medical Research Council, National Health and Medical Research Council

Openalex Percentile: Top 67%

Substance Abuse Treatment and Outcomes

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

N-acetyl cysteine for the treatment of alcohol use disorder: study protocol for a multi-site, double-blind randomised controlled trial (NAC-AUD study) — Kirsten C. Morley, Jason P. Connor, et al. · BMJ Open (2025) | TGRS Research Map | TGRS